Background—Pulmonary hypertension (PH) frequently coexists with severe aortic stenosis,
and PH severity has been shown to predict outcomes after transcatheter aortic valve …

Pulmonary hypertension (PH) is a common entity in patients with severe aortic stenosis (AS)
who underwent transcatheter aortic valve implantation (TAVI), but its role on clinical …

Objectives: The aim of this study was to investigate the prognostic impact and development
of pulmonary hypertension (PH) in the different hemodynamic subtypes of PH in patients …

Objective Pulmonary hypertension (PH) is associated with increased mortality after surgical
or transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS), and when the …

Limited amount of data suggest that patients with aortic stenosis and pulmonary
hypertension (PH) who undergo transcatheter aortic valve replacement (TAVR) experience …

Aims: Transcatheter aortic valve replacement (TAVR) is established as a treatment strategy
for patients with end-stage aortic stenosis, many of whom are suffering from severe …

Background There are limited data on the prognostic impact of periprocedural pulmonary
hypertension (PH) after transcatheter aortic valve replacement (TAVR). Objectives The aim …

Background—Pulmonary hypertension (PH) is associated with poor prognosis in patients
with severe aortic stenosis. The aim of this multicenter study was to describe clinical …

Objectives: The authors investigated the development of pulmonary hypertension (PH),
predictors of PH regression, and its prognostic impact on short, mid-, and long-term …

Background—Severe pulmonary hypertension (PH) is considered to negatively affect the
outcome after transcatheter aortic valve replacement. However, a clear understanding of the …